The N676D and G697R mutations in the kinase domain of FLT3 confer resistance to the inhibitor AC220
D. Pauwels(Center for Human Genetics), Jan Cools(KU Leuven)
Cited by 29
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
|Nature Cancer|2023|140